alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
**EXHIBIT 99.1**

 

**Certification of Principal Executive Officer**

**Pursuant to 18 U.S.C. 1350 (Section 906 of the Sarbanes-Oxley Act of 2002)**

 

I, Thomas F. August, President and Chief Executive Officer, of PrentissProperties Trust (the “Registrant”), do hereby certify, pursuant to 18 U.S. C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge, based upon a review of the Annual Reporton Form 10-K for the period ended December 31, 2002 of the Registrant, as filed with the Securities and Exchange Commission on the date hereof (the “Report”): 

 

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Actof 1934, as amended (15 U.S.C. Section 78m(a) or Section78o(d)); and 

 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant. 

 

    /s/ Thomas F. August 

    Thomas F. August 

    President & ChiefExecutive Officer 

    March 25, 2003 

 

STATE OF TEXAS§ 

COUNTY OF DALLAS§ 

 

Subscribed and sworn tobefore me this 25th day of March 2003. 

 

/s/ Lana Mann

Lana Mann 

March 25, 2003

 

Notary Public 

My Commission Expires: 5/26/2005 

Official Seal
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000
       
<S>                                        <C>
<PERIOD-TYPE>                              9-MOS
<FISCAL-YEAR-END>                          FEB-25-1996
<PERIOD-START>                             FEB-27-1995
<PERIOD-END>                               NOV-26-1995
<CASH>                                           1,155
<SECURITIES>                                         0
<RECEIVABLES>                                    6,961
<ALLOWANCES>                                   (1,134)
<INVENTORY>                                      1,264
<CURRENT-ASSETS>                                 9,009
<PP&E>                                          16,450
<DEPRECIATION>                                (11,969)
<TOTAL-ASSETS>                                  17,250
<CURRENT-LIABILITIES>                            7,501
<BONDS>                                              0
<COMMON>                                        21,238
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<OTHER-SE>                                    (11,721)
<TOTAL-LIABILITY-AND-EQUITY>                    17,250
<SALES>                                         11,490
<TOTAL-REVENUES>                                25,418
<CGS>                                            6,962
<TOTAL-COSTS>                                   16,410
<OTHER-EXPENSES>                                 9,836
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                  26
<INCOME-PRETAX>                                  (504)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                              (504)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     (504)
<EPS-PRIMARY>                                   (0.08)
<EPS-DILUTED>                                   (0.08)
        

</TABLE>
Reporting

Entity Recipient

Name Recipient

Business street address Recipient

Specialty *physician only Recipient

National Provider Identifier (NPI) *physician only Amount of

Payment (US dollars) Date of

Payment Notes: Please submit this template as a Comma Separated Value (CSV) file Recipient = Covered Recipient or Physician Owner or Investor Form of payment must be 1) cash or cash equivalent, 2) in-kind items or services, 3) stock, a stock option, or any other ownership interest, dividend, profit, or other return on investment Nature of payment must be 1) Consulting fee, 2) Compensation for services other than consulting, 3) Honoraria, 4) Gift, 5) Entertainment, 6) Food and beverage, 7) Travel and lodging, 8) Education, 9) Direct Research, 10) Indirect Research, 11) Charitable contribution, 12)Royalty or license, 13) Current or prospective ownership of investment interests, 14) Direct compensation for serving as a faculty or as a speaker for a medical education program, 15) Grant, or 16) OtherForm of

Payment Nature of

Payment Name of

Associated Drug, Device, Biological, or Medical Supply *if

necessary Entity Paid

Name Physician

Owner or Investor (y/n) Delayed

Publication (y/n) Form of payment must be 1) cash or cash equivalent, 2) in-kind items or services, 3) stock, a stock option, or any other ownership interest, dividend, profit, or other return on investment Nature of payment must be 1) Consulting fee, 2) Compensation for services other than consulting, 3) Honoraria, 4) Gift, 5) Entertainment, 6) Food and beverage, 7) Travel and lodging, 8) Education, 9) Direct Research, 10) Indirect Research, 11) Charitable contribution, 12)Royalty or license, 13) Current or prospective ownership of investment interests, 14) Direct compensationReporting

Entity Recipient

Name Recipient

Business street address Recipient

Specialty *physician only Recipient

National Provider Identifier (NPI) *physician only Interest Held

by Immediate Family Member (y/n) Dollar Amount

Invested Notes: Please submit this template as a Comma Separated Value (CSV) file Owner = Physician Owner or Investor All payments or other tranfers of value provided to physician owners or investors must be reported on the Payment & Transfer of Value tab and designated as that to a physician owner or investor.Value of

Interest Terms of

Interest All payments or other tranfers of value provided to physician owners or investors must be reported on the Payment & Transfer of Value tab and
[Federal Register Volume 89, Number 15 (Tuesday, January 23, 2024)]
[Notices]
[Page 4278]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-01241]


-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

National Oceanic and Atmospheric Administration

[RTID 0648-XD665]


Takes of Marine Mammals Incidental to Specified Activities; 
Taking Marine Mammals Incidental to Marine Site Characterization 
Surveys off New York, New Jersey, Delaware, and Maryland; Correction

AGENCY: National Marine Fisheries Service (NMFS), National Oceanic and 
Atmospheric Administration (NOAA), Commerce.

ACTION: Notice; correction.

-----------------------------------------------------------------------

SUMMARY: This notice contains a correction to the Summary of Request 
section of the notice of proposed incidental harassment authorization 
(IHA) for the taking of marine mammals incidental to marine site 
characterization surveys in waters off of New York, New Jersey, 
Delaware, and Maryland published in the Federal Register on January 5, 
2024. That notice included an incorrect website address for accessing 
monitoring results submitted by Atlantic Shores Offshore Wind, LLC 
under previous IHAs. This notice provides a correction to that website 
address; all other information is unchanged.

FOR FURTHER INFORMATION CONTACT: Alyssa Clevenstine, Office of 
Protected Resources, NMFS, (301) 427-8401.

SUPPLEMENTARY INFORMATION:

Correction

    In the Federal Register of January 5, 2024, in FR Doc. 2024-00008, 
on page 754, in the third column, correct the sentence in the Summary 
of Request section to read:
    These previous monitoring results are available to the public on 
our website: https://www.fisheries.noaa.gov/action/incidental-take-authorization-atlantic-shores-offshore-wind-llc-marine-site-characterization and https://www.fisheries.noaa.gov/action/incidental-take-authorization-atlantic-shores-offshore-wind-bight-llc-marine-site.

    Dated: January 18, 2024.
Kimberly Damon-Randall,
Director, Office of Protected Resources, National Marine Fisheries 
Service.
[FR Doc. 2024-01241 Filed 1-22-24; 8:45 am]
BILLING CODE 3510-22-P
#### Michael Gregory EGGERT, Petitioner-Appellant, v. Robert DOYLE, Marin County Sheriff; Ronald Baylo, Chief of the Marin County Probation Office, Respondents-Appellees.

No. 02-15406.

D.C. No. CV-00-21245-RMW.

United States Court of Appeals, Ninth Circuit.

*851Submitted Feb. 10, 2003.*

Decided Feb. 12, 2003.

Before LEAVY, FERNANDEZ, and BERZON, Circuit Judges.

*

 This panel unanimously finds this case suitable for decision without oral argument. *See*Fed. R.App. P. 34(a)(2). Accordingly, petitioner’s request for oral argument is denied.

MEMORANDUM**

Michael Gregory Eggert, a former California state prisoner, appeals the district court’s denial of his 28 U.S.C. § 2254 petition challenging his 30-day sentence for driving under the influence. We dismiss this appeal as moot because Eggert admits that he has completed serving his entire sentence, and he thus lacks standing to raise any challenge to it.1*See United States v. Palomba,*182 F.3d 1121, 1123 (9th Cir.1999) (citing *Spencer v. Kemna,*523 U.S. 1, 118 S.Ct. 978, 140 L.Ed.2d 43 (1998)).

DISMISSED.

**

 This disposition is not appropriate for publication and may not be cited to or by the courts of this circuit except as provided by Ninth Circuit Rule 36-3.

1

. Moreover, as the district court concluded, there is no merit to Eggert's claim. *See Cor-bitt v. New Jersey,*439 U.S. 212, 219, 99 S.Ct. 492, 58 L.Ed.2d 466 (1978) (stating that a State may encourage a guilty plea by offering substantial benefits in return for the plea).
<PAGE>

                                  EXHIBIT 31.1

                                 CERTIFICATIONS

I, Gary S. Jacob, certify that:

1) I have reviewed this quarterly report on Form 10-QSB/A of Callisto
Pharmaceuticals, Inc.

2) Based on my knowledge, this quarterly report does not contain any untrue
statement of a material fact or omit to state a material fact necessary to make
the statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this quarterly
report;

3) Based on my knowledge, the financial statements, and other financial
information included in this quarterly report, fairly present in all material
respects the financial condition, results of operations and cash flows of the
registrant as of, and for, the periods presented in this quarterly report;

4) The registrant's other certifying officers and I am responsible for
establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-14 and 15d-14) for the registrant and we have:

a) Designed such disclosure controls and procedures, or caused such disclosure
controls and procedures to be designed under our supervision, to ensure that
material information relating to the registrant, including its consolidated
subsidiaries, is made known to us by others within those entities, particularly
during the period in which this quarterly report is being prepared;

b) Evaluated the effectiveness of the registrant's disclosure controls and
procedures and presented in this report our conclusions about the effectiveness
of the disclosure controls and procedures, as of the end of the period covered
by this report based on such evaluation; and

c) Disclosed in this report any change in the registrant's internal control over
financial reporting that occurred during the registrant's most recent fiscal
quarter (the registrant's fourth fiscal quarter in the case of an annual report)
that has materially affected, or is reasonably likely to materially affect, the
registrant's internal control over financial reporting; and

5) The registrant's other certifying officers and I have disclosed, based on our
most recent evaluation of internal control over financial reporting, to the
registrant's auditors and the audit committee of the registrant's board of
directors (or persons performing the equivalent functions);

a) All significant deficiencies and material weaknesses in the design or
operation of internal control over financial reporting which are reasonably
likely to adversely affect the registrant's ability to record, process,
summarize and report financial information; and b) Any fraud, whether or not
material, that involves management or other employees who have a significant
role in the registrant's internal control over financial reporting.

Date: July 2, 2004





                 /s/ Gary S. Jacob
                 -----------------
                 Gary S. Jacob
                 Chief Executive Officer
EXHIBIT
32.1





CERTIFICATION
PURSUANT TO


18 U.S.C.
SECTION1350,


AS
ADOPTED PURSUANT TO


SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002





In
connection with the Quarterly Report of Global Entertainment Holdings, Inc. (the
"Company") on Form 10-QSB for the period ended June 30, 2008, as filed with the
Securities and Exchange Commission on the date hereof (the "Report"), I, Gary
Rasmussen, Chief Executive Officer of the Company, certify, pursuant to 18
U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002, that:





(1)
            The
      Report fully complies with the requirements of Section 13(a) or 15(d) of
      the Securities Exchange Act of 1934;
and





(2)
            The
      information contained in the Report fairly presents, in all material
      respects, the financial condition and results of operations of the
      Company.











/s/ Gary
Rasmussen


Gary Rasmussen


Chief Executive Officer


August 14, 2008
**Panel Member Roster for December 4** 
**- 6**  **, 201 3** 

**Meeting of the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) Scientific Advisory Panel (SAP) on**  **Scientific U**  **ncertainties A**  **ssociated with C**  **orn R** **ootworm R**  **esistance M**  **onitoring for Bt corn Plant Incorporated Protectants (PIPs)**

**Docket Number: EP** **A**
**- HQ** 
**- OPP** 
**- 201**  **3**
**- 0490**  **FI FRA SAP Chair**  **Daniel Schlenk, Ph.D.** Professor of Aquatic Ecotoxicology & Environmental Toxicology Department of Environmental Sciences University

of Cali fornia, Riverside Riverside, CA **Designated Federal Official Fred Jenkins, Jr., Ph.D.**  US Environmental Protection Agency Office of Science Coordination & Policy FIFRA Scientific Advisory Panel EPA East Building, MC 7201M 1200 Pennsylvania Avenue, NW Washington, DC 20460 Phone (202) 564

- 3327 Fax (202) 564

- 8382 jenkins.fred@epa.gov **FI FRA Scientific Advisory Panel Members**  **Kenneth Delclos** , **Ph.D.** Pharmacologist National Center for Toxicological Research U.S. Food and Drug Administration Jefferson, AR **James McManaman, Ph.D.** Professor & Chief Section of Basic Reproductive Sciences Department of Obstetrics & Gy necology , Phy siology

& Biophy sics University

of Colorado, Denver Aurora, CO**Prakash Nagarkatti, Ph.D.**

Vice President for Research Carolina D istinguished Professor University

of South Carolina Columbia, SC **FQ PA Science Review Board Members**  **Carlos Blanco, Ph.D.** Biotechnologist US Department of Agriculture Animal and Plant Health Inspection Service Riverdale, MD **Shelby Fleischer, Ph.D.** Professor of Entomology Pennsylvania State University University

Park, PA **Susan T. Ratcliffe , Ph.D.**  Director North Central Regional Integrated Pest Management Center Department of Crop Sciences University

of Illinois at Urbana

- Champaign Urbana, IL **Mark Sears**  **, Ph.D.** Professor Emeritus Environmental Biology University

of Guelph Guelph, Ontario, Canada **Stefan Toe p**  **fer, Ph.D.** Integrated Crop Management Advisor, Biological Control Research Scientist CABI Europe

– Switzerland Hodmezovasarhel y, Hungary
Exhibit 21.1

                            D&E Communications, Inc.

                           Subsidiaries of the Company
                             as of December 31, 1997
--------------------------------------------------------------------------------

The following is a listing of all subsidiaries of the Registrant, the state of
incorporation of each, and the names under which subsidiaries do business.

<TABLE>
<CAPTION>
                                       State of               Doing Business
       Subsidiary                    Incorporation             Under Name of
       ----------                    -------------            --------------
<S>                                  <C>                   <C>
Denver and Ephrata Telephone
     and Telegraph Company           Pennsylvania          D&E Telephone Company

D&E Telephone and Data                                     D&E Telephone and Data
     Systems, Inc.                   Pennsylvania             Systems, Inc.,
                                                           D&E Long Distance,
                                                           D&E Telestore, and
                                                           D&E Computer Networking
                                                               Services

D&E Marketing Corp.                  Pennsylvania          D&E Marketing Corp.

D&E Wireless, Inc.                   Pennsylvania          D&E Wireless, Inc.

D&E Investments, Inc.                Nevada                D&E Investments, Inc.

D&E Holdings, L.P.                   Pennsylvania          D&E Holdings, L.P.

</TABLE>
II

104TH CONGRESS

2D SESSION S. 1588

To authorize the Secretary of Transportation to issue a certificate of

documentation and coastwise trade endorsement for the vessel KALYPSO.

IN THE SENATE OF THE UNITED STATES

MARCH 5, 1996

Mr. STEVENS introduced the following bill; which was read twice and referred

to the Committee on Commerce, Science, and Transportation

A BILL

To authorize the Secretary of Transportation to issue a

certificate of documentation and coastwise trade endorsement for the vessel KALYPSO.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,

3 That notwithstanding sections 12106, 12107, and 12108

4 of title 46, United States Code, and section 27 of the Mer5 chant Marine Act, 1920 (46 App. U.S.C. 883), as applica6 ble on the date of enactment of this Act, the Secretary

7 of Transportation may issue a certificate of documentation

8 with appropriate endorsements for employment in the
2

•S 1588 IS

1 coastwise trade for the vessel KALYPSO (vessel number

2 566349).

Æ
FIRST DISTRICT COURT OF APPEAL

STATE OF FLORIDA

_____________________________

No. 1D18-95

_____________________________

DIANA COSTARAKIS,

Appellant,

v.

STATE OF FLORIDA,

Appellee.

_____________________________

On appeal from the Circuit Court for Duval County.

Marianne L. Aho, Judge.

April 24, 2019

PER CURIAM.

AFFIRMED.

B.L. THOMAS, C.J., and ROBERTS and OSTERHAUS, JJ., concur.

_____________________________

Not final until disposition of any timely and 

authorized motion under Fla. R. App. P. 9.330 or 

9.331.

_____________________________
2

W. Charles Fletcher of Law Office of W. Charles Fletcher, 

Jacksonville, for Appellant.

Ashley Moody, Attorney General, Tallahassee, for Appellee.
<PAGE>   1





                                                                    EXHIBIT (24)

                                  PROFESSIONALS GROUP, INC.

        KNOW ALL MEN by these presents that each of the undersigned hereby make,
constitute and appoint Victor T. Adamo, R. Kevin Clinton and John F. Lang, and
each of them, the true and lawful attorney-in-fact of the undersigned, with full
power of substitution and revocation, for and in the name, place and stead of
the undersigned, to execute, deliver and file (with the Securities and Exchange
Commission or any other appropriate governmental authority) the Annual Report on
Form 10-K of Professionals Group, Inc. for the year ended December 31, 2000, and
any and all amendments thereto; such Form 10-K and each such amendment to be in
such form and to contain such terms and provisions as said attorney or
substitute shall deem necessary or desirable; giving and granting unto said
attorney, or to such person or persons as in any case may be appointed pursuant
to the power of substitution herein given, full power and authority to do and
perform any and every act and thing whatsoever requisite, necessary or, in the
opinion of said attorney or substitute, able to be done in and about the
premises as fully and to all intents and purposes as the undersigned might or
could do if personally present, hereby ratifying and confirming all that said
attorney for such substitute shall lawfully do or cause to be done by virtue
hereof.

        IN WITNESS WHEREOF, each of the undersigned has duly executed this
instrument as of the 27th day of March, 2001.



/s/ Victor T. Adamo                                    /s/ Richard P. Horsch
--------------------------------                      --------------------------
Victor T. Adamo                                       Richard P. Horsch


/s/ Eliot H. Berg                                     /s/ Isaac J. Powell
--------------------------------                      --------------------------
Eliot H. Berg                                         Isaac J. Powell


/s/ Joseph C. Cauthen                                 /s/ Ann F. Putallaz
--------------------------------                      --------------------------
Joseph C. Cauthen                                     Ann F. Putallaz


/s/ R. Kevin Clinton                                  /s/ William H. Woodhams
--------------------------------                      -------------------------
R. Kevin Clinton                                      William H. Woodhams


/s/ John F. Dodge, Jr.                                /s/ Donald S. Young
-------------------------------                       --------------------------
John F. Dodge, Jr.                                    Donald S. Young


/s/ H. Harvey Gass
------------------------------
H. Harvey Gass